MedTrace Logo

Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological Deficit

NCT06772311 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-01-13

No results posted yet for this study

Summary

The goal of this observational study was to learn about the long-term clinical efficacy of conservative treatment in atlantoaxial dislocation patients without neurological deficit. The main question it aims to answer is:

Is surgical intervention always necessary in atlantoaxial dislocation patients without nerve deficit?

Patients who refuse surgical intervention will continue to be treated conservatively. Clinical outcomes will be summarized over five years of follow-up

Conditions

  • Atlantoaxial Dislocation

Sponsors & Collaborators

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Shanxi Medical University Second Hospital

    collaborator UNKNOWN

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    collaborator OTHER

  • Hebei Medical University Third Hospital

    collaborator OTHER

  • Shanxi Bethune Hospital

    collaborator OTHER

  • Daping Hospital of Army Medical University

    collaborator OTHER

  • Shengjing Hospital

    collaborator OTHER

  • Tianjin People's Hospital

    collaborator OTHER

  • First Affiliated Hospital of Kunming Medical University

    collaborator OTHER

  • Affiliated hospital of Guilin medical university,China

    collaborator UNKNOWN

  • Peking University Third Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2025-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06772311 on ClinicalTrials.gov